As of 2025-07-09, the Relative Valuation of Crescita Therapeutics Inc (CTX.TO) is (0.02) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.49 CAD, the upside of Crescita Therapeutics Inc based on Relative Valuation is -103.3%.
The range of the Relative Valuation is (0.01) - (0.02) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 0.1x | 0.1x |
| Forward P/E multiples | 0.1x - 0.1x | 0.1x |
| Fair Price | (0.01) - (0.02) | (0.02) |
| Upside | -102.7% - -104.0% | -103.3% |
| Date | P/E |
| 2025-07-07 | -3.02 |
| 2025-07-02 | -3.02 |
| 2025-06-30 | -3.08 |
| 2025-06-27 | -3.08 |
| 2025-06-25 | -3.05 |
| 2025-06-24 | -3.02 |
| 2025-06-20 | -3.02 |
| 2025-06-19 | -3.02 |
| 2025-06-18 | -3.17 |
| 2025-06-11 | -3.11 |
| 2025-06-10 | -2.99 |
| 2025-06-09 | -2.99 |
| 2025-06-06 | -2.92 |
| 2025-06-05 | -3.36 |
| 2025-06-04 | -3.30 |
| 2025-06-03 | -3.30 |
| 2025-06-02 | -3.23 |
| 2025-05-30 | -3.11 |
| 2025-05-28 | -3.11 |
| 2025-05-27 | -3.17 |
| 2025-05-26 | -3.36 |
| 2025-05-23 | -3.36 |
| 2025-05-22 | -3.36 |
| 2025-05-21 | -3.36 |
| 2025-05-20 | -3.36 |
| 2025-05-15 | -3.17 |
| 2025-05-14 | -3.23 |
| 2025-05-13 | -3.30 |
| 2025-05-12 | -3.42 |
| 2025-05-07 | -3.48 |
| 2025-05-06 | -3.61 |
| 2025-05-05 | -3.42 |
| 2025-05-02 | -3.61 |
| 2025-04-30 | -3.61 |
| 2025-04-29 | -3.61 |
| 2025-04-28 | -3.61 |
| 2025-04-24 | -3.55 |
| 2025-04-22 | -3.55 |
| 2025-04-21 | -3.48 |
| 2025-04-16 | -3.67 |
| 2025-04-15 | -3.73 |
| 2025-04-14 | -3.61 |